3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 1 0 0 0 0 0999 V2000
3.5498 0.6400 0.5353 S 0 0 0 0 0 0 0 0 0 0 0 0
3.3961 -1.9056 -0.1424 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5918 -0.5174 -0.6494 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0958 0.8269 -0.4341 C 0 0 1 0 0 0 0 0 0 0 0 0
0.1398 0.8686 0.7560 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3118 1.7243 -0.2380 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2229 0.3471 0.3909 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8353 -0.8204 -0.1406 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1970 1.2207 -0.0925 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5126 -1.0095 0.5356 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4609 0.7374 -0.4313 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7764 -1.4928 0.1969 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7506 -0.6193 -0.2865 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5725 1.1347 -1.3477 H 0 0 0 0 0 0 0 0 0 0 0 0
0.0238 1.9013 1.1110 H 0 0 0 0 0 0 0 0 0 0 0 0
0.5328 0.3049 1.6123 H 0 0 0 0 0 0 0 0 0 0 0 0
2.7116 2.0419 -1.2071 H 0 0 0 0 0 0 0 0 0 0 0 0
2.1150 2.6143 0.3656 H 0 0 0 0 0 0 0 0 0 0 0 0
1.0192 -1.2273 -1.0955 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.9833 2.2795 -0.2122 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.7636 -1.7006 0.9130 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.2193 1.4173 -0.8083 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.0022 -2.5491 0.3099 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.7347 -0.9957 -0.5503 H 0 0 0 0 0 0 0 0 0 0 0 0
1 6 1 0 0 0 0
1 8 1 0 0 0 0
2 8 2 0 0 0 0
3 4 1 0 0 0 0
3 8 1 0 0 0 0
3 19 1 0 0 0 0
4 5 1 0 0 0 0
4 6 1 0 0 0 0
4 14 1 0 0 0 0
5 7 1 0 0 0 0
5 15 1 0 0 0 0
5 16 1 0 0 0 0
6 17 1 0 0 0 0
6 18 1 0 0 0 0
7 9 2 0 0 0 0
7 10 1 0 0 0 0
9 11 1 0 0 0 0
9 20 1 0 0 0 0
10 12 2 0 0 0 0
10 21 1 0 0 0 0
11 13 2 0 0 0 0
11 22 1 0 0 0 0
12 13 1 0 0 0 0
12 23 1 0 0 0 0
13 24 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(4S)-4-benzyl-1,3-thiazolidin-2-one
4.2 InChl
InChI=1S/C10H11NOS/c12-10-11-9(7-13-10)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,11,12)/t9-/m0/s1
4.3 InChlKey
HOTCRDXCVRFUOW-VIFPVBQESA-N
4.4 Canonical SMILES
C1C(NC(=O)S1)CC2=CC=CC=C2
4.5 lsomeric SMILES
C1[C@@H](NC(=O)S1)CC2=CC=CC=C2
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病